3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain
19
Neoplasms
17
Cancer Pain
15
Pain, Postoperative
12
Agnosia
8
Chronic Pain
7
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms
4
Multiple Myeloma
3
Mucositis
3
Lymphoma, Follicular
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Wounds and Injuries
2
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Supratentorial Neoplasms
2
Sezary Syndrome
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Pancreatic Neoplasms
2
Interventions
Bevacizumab
4
Temozolomide
3
Irinotecan
3
Sorafenib
2
Radiosurgery
2
pembrolizumab
1
ibrutinib
1
Vorinostat
1
Valproic Acid
1
Transcranial Magnetic Stimulation
1
Therapeutics
1
Thalidomide
1
Standard of Care
1
Sildenafil Citrate
1
Radiotherapy
1
Pliability
1
Plasma Exchange
1
Palliative Care
1
Nivolumab
1
Morphine
1
Methadone
1
Lenalidomide
1
Immunoglobulins
1
Exercise
1
Equipment and Supplies
1
Clomipramine
1
Carboplatin
1
Bendamustine Hydrochloride
1
Atorvastatin
1
Amifampridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neurologic Manifestations
×
Morphine
×
Clear all
NCT04475029
2023-09-13
METAMORF
University of Aarhus
Phase NA
Completed
114 enrolled